16.22
price down icon1.88%   -0.31
after-market アフターアワーズ: 16.22
loading
前日終値:
$16.53
開ける:
$16.15
24時間の取引高:
282.23K
Relative Volume:
1.08
時価総額:
$842.39M
収益:
-
当期純損益:
$-85.21M
株価収益率:
-8.582
EPS:
-1.89
ネットキャッシュフロー:
$-68.53M
1週間 パフォーマンス:
-5.64%
1か月 パフォーマンス:
-23.06%
6か月 パフォーマンス:
-43.82%
1年 パフォーマンス:
-6.13%
1日の値動き範囲:
Value
$15.44
$16.82
1週間の範囲:
Value
$15.44
$18.14
52週間の値動き範囲:
Value
$13.30
$30.03

Enliven Therapeutics Inc Stock (ELVN) Company Profile

Name
名前
Enliven Therapeutics Inc
Name
セクター
Healthcare (1182)
Name
電話
720-647-8519
Name
住所
6200 LOOKOUT ROAD, BOULDER
Name
職員
62
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ELVN's Discussions on Twitter

ELVN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ELVN
Enliven Therapeutics Inc
16.22 842.39M 0 -85.21M -68.53M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-13 開始されました BTIG Research Buy
2024-09-09 開始されました H.C. Wainwright Buy
2024-06-11 開始されました Robert W. Baird Outperform
2024-04-09 開始されました Mizuho Buy
2023-03-29 開始されました Jefferies Buy

Enliven Therapeutics Inc (ELVN) 最新ニュース

pulisher
Apr 20, 2025

Geode Capital Management LLC Acquires 12,510 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 20, 2025
pulisher
Apr 15, 2025

(ELVN) Trading Report - news.stocktradersdaily.com

Apr 15, 2025
pulisher
Apr 13, 2025

Vanguard Group Inc. Purchases 55,283 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Stake Boosted by Wellington Management Group LLP - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

KLP Kapitalforvaltning AS Makes New $97,000 Investment in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Ratios Revealed: Decoding Enliven Therapeutics Inc (ELVN)’s Financial Health - DWinneX

Apr 10, 2025
pulisher
Apr 10, 2025

Corebridge Financial Inc. Trims Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

Enliven Therapeutics COO Anish Patel sells shares worth $120,268 - Investing.com Australia

Apr 09, 2025
pulisher
Apr 06, 2025

Wall Street Analysts See a 58.78% Upside in Enliven Therapeutics, Inc. (ELVN): Can the Stock Really Move This High? - MSN

Apr 06, 2025
pulisher
Apr 02, 2025

Enliven Therapeutics Announces Poster Presentations at the 2025 AACR Annual Meeting - StreetInsider

Apr 02, 2025
pulisher
Apr 02, 2025

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 4.9% After Insider Selling - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Enliven Therapeutics CFO Benjamin Hohl sells $69,320 in stock By Investing.com - Investing.com UK

Apr 01, 2025
pulisher
Mar 31, 2025

Enliven Therapeutics CFO Benjamin Hohl sells $69,320 in stock - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Where are the Opportunities in (ELVN) - news.stocktradersdaily.com

Mar 30, 2025
pulisher
Mar 30, 2025

Swiss National Bank Increases Stock Position in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 30, 2025
pulisher
Mar 27, 2025

Enliven Therapeutics CFO sells $22,504 in stock By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 26, 2025

Enliven Therapeutics CFO sells $22,504 in stock - Investing.com India

Mar 26, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Grows Stock Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 25, 2025
pulisher
Mar 23, 2025

HC Wainwright Forecasts Strong Price Appreciation for Enliven Therapeutics (NASDAQ:ELVN) Stock - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Sells 828 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Enliven Therapeutics chief scientific officer sells $257,575 in stock By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Enliven Therapeutics chief scientific officer sells $257,575 in stock - Investing.com India

Mar 21, 2025
pulisher
Mar 20, 2025

Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

(ELVN) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 20, 2025
pulisher
Mar 20, 2025

Lifesci Capital Issues Optimistic Forecast for ELVN Earnings - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Enliven Therapeutics CEO Samuel Kintz sells $260,320 in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Enliven Therapeutics CEO Samuel Kintz sells $260,320 in stock By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 15, 2025

Decoding Enliven Therapeutics Inc (ELVN): A Strategic SWOT Insig - GuruFocus.com

Mar 15, 2025
pulisher
Mar 14, 2025

Enliven grew fourth-quarter R&D spending with trials underway - BizWest

Mar 14, 2025
pulisher
Mar 14, 2025

Enliven Therapeutics Stock (ELVN): Promising Advances in Oncology Pipeline - Value The Markets

Mar 14, 2025
pulisher
Mar 14, 2025

Enliven Therapeutics Reports 2024 Financial Results - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - Citizentribune

Mar 13, 2025
pulisher
Mar 13, 2025

Enliven Therapeutics Inc. (ELVN) reports earnings - Quartz

Mar 13, 2025
pulisher
Mar 13, 2025

Enliven Therapeutics Q4 Operating Expenses USD 26.896 Million -March 13, 2025 at 05:37 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ENLIVEN THERAPEUTICS Earnings Results: $ELVN Reports Quarterly Earnings - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Enliven Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Earnings Flash (ELVN) Enliven Therapeutics Posts Q4 Loss $-0.46 Per Share -March 13, 2025 at 04:12 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Enliven Therapeutics Secures 3-Year Runway with $313M War Chest, Advances Cancer Drug Pipeline - Stock Titan

Mar 13, 2025
pulisher
Mar 11, 2025

Enliven Therapeutics COO Anish Patel sells $142,936 in stock - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Enliven Therapeutics COO Anish Patel sells $142,936 in stock By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 09, 2025

(ELVN) Investment Analysis and Advice - Stock Traders Daily

Mar 09, 2025
pulisher
Mar 06, 2025

Enliven Therapeutics (ELVN) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

New York State Common Retirement Fund Sells 2,488 Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World

Mar 05, 2025
pulisher
Mar 03, 2025

Enliven Therapeutics CFO Sells Shares - TradingView

Mar 03, 2025
pulisher
Mar 01, 2025

Enliven Therapeutics CFO sells $22,524 in stock - MSN

Mar 01, 2025
pulisher
Feb 25, 2025

Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - Longview News-Journal

Feb 25, 2025

Enliven Therapeutics Inc (ELVN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):